{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T10:54:26Z","timestamp":1788173666304,"version":"build-2803163510"},"reference-count":36,"publisher":"BMJ","issue":"2","funder":[{"DOI":"10.13039\/501100005809","name":"Hyderabad Eye Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"accepted":{"date-parts":[[2025,8,13]]},"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To conduct an analysis of ophthalmic manifestations in leukaemic patients and evaluate their impact on visual outcomes and disease remission.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective, comparative study included 244 patients (378 eyes) diagnosed with leukaemias between January 2016 and 2024. Data included demography, leukaemia type, ophthalmic manifestations, imaging modalities, treatment modalities (ocular and systemic), treatment outcomes (relapses or remission) and final visual acuity. Univariate and multivariate regression analyses were performed to identify correlations and predictive features associated with visual outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The mean age of patients was 34.9\u00b122.1 years (range, 1\u201388 years). Acute lymphocytic leukaemia was the most common subtype (58%), followed by chronic myeloid leukaemia (CML; 20%). Acute forms manifested earlier in life and were more aggressive. The presence of posterior segment manifestations (64%) was more than anterior segment manifestations (52%). Myeloid leukaemia types were more often associated with haemorrhagic manifestations, whereas lymphoid types were associated with non-haemorrhagic manifestations. Univariate regression analysis showed that the presence of epiretinal membrane (OR 0.110, 95%\u2009CI 0.012 to 0.951, p=0.04), submacular haemorrhage (OR 0.091, 95%\u2009CI 0.010 to 0.763, p=0.027) and type of leukaemia (acute myeloid leukaemia (AML) (OR 3.195, 95%\u2009CI 1.697 to 6.012, p&lt;0.000) or CML (OR 6.39, 95%\u2009CI 3.130 to 13.041, p&lt;0.000)) had significant association with poor visual outcome. Multivariate regression analysis revealed AML (OR 2.769, 95%\u2009CI 1.392 to 5.507, p=0.004) and CML (OR 7.313, 95%\u2009CI 3.326 to 16.074, p&lt;0.000) as independent predictors of poor visual outcome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Ophthalmic manifestations are major diagnostic and prognostic clues for leukaemias. Pattern recognition facilitates timely recognition, risk stratification, management and disease remission prediction.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bjo-2025-327835","type":"journal-article","created":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T17:20:20Z","timestamp":1756401620000},"page":"219-225","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Ophthalmic manifestations and treatment outcomes in leukaemia: a comparative analysis of clinical spectrum, visual prognosis and predictors of disease remission across subtypes"],"prefix":"10.1136","volume":"110","author":[{"given":"Dhwanee","family":"Agarwal","sequence":"first","affiliation":[{"name":"Anant Bajaj Retina Institute, LV Prasad Eye Institute GMR Varalakshmi Campus, Visakhapatnam, Andhra Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9211-917X","authenticated-orcid":false,"given":"Mudit","family":"Tyagi","sequence":"additional","affiliation":[{"name":"Smt Kanuri Santhamma Centre for Vitreo Retinal Diseases, L V Prasad Eye Institute, Hyderabad, India"},{"name":"Anant Bajaj Retina Institute, L V Prasad Eye Institute, Hyderabad, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeev K R","family":"Pappuru","sequence":"additional","affiliation":[{"name":"Smt Kanuri Santhamma Centre for Vitreo Retinal Diseases, L V Prasad Eye Institute, Hyderabad, India"},{"name":"Anant Bajaj Retina Institute, L V Prasad Eye Institute, Hyderabad, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8446-2696","authenticated-orcid":false,"given":"Vishal","family":"Raval","sequence":"additional","affiliation":[{"name":"Smt Kanuri Santhamma Centre for Vitreo Retinal Diseases, L V Prasad Eye Institute, Hyderabad, India"},{"name":"Anant Bajaj Retina Institute, L V Prasad Eye Institute, Hyderabad, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,8,28]]},"reference":[{"key":"2026012202151213000_110.2.219.1","article-title":"Leukemia in India: Insights Into Incidence, Prevalence, Mortality, and Disability-Adjusted Life Years","volume":"16","author":"Nalage","year":"2024","journal-title":"Cureus"},{"key":"2026012202151213000_110.2.219.2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-03-643544"},{"key":"2026012202151213000_110.2.219.3","doi-asserted-by":"crossref","unstructured":"Li W . The 5th edition of the world health organization classification of hematolymphoid tumors. In: Leukemia. 2022: 1\u201321.","DOI":"10.36255\/exon-publications-leukemia-who-5th-edition-hematolymphoid-tumors"},{"key":"2026012202151213000_110.2.219.4","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0002-9394(14)74610-0","article-title":"Analysis of 135 autopsy eyes for ocular involvement in leukemia","volume":"109","author":"Leonardy","year":"1990","journal-title":"Am J Ophthalmol"},{"key":"2026012202151213000_110.2.219.5","doi-asserted-by":"publisher","DOI":"10.1016\/0039-6257(83)90123-6"},{"key":"2026012202151213000_110.2.219.6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.oret.2017.05.009","article-title":"Ocular Manifestations in Leukemias and Their Correlation with Hematologic Parameters at a Tertiary Care Setting in South India","volume":"2","author":"Soman","year":"2018","journal-title":"Ophthalmol Retina"},{"key":"2026012202151213000_110.2.219.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(83)80013-X"},{"key":"2026012202151213000_110.2.219.8","doi-asserted-by":"publisher","DOI":"10.1046\/j.1600-0420.2003.00197.x"},{"key":"2026012202151213000_110.2.219.9","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/sj.eye.6701308","article-title":"Ophthalmic manifestations of acute leukaemias: the ophthalmologist\u2019s role","volume":"18","author":"Sharma","year":"2004","journal-title":"Eye (Lond)"},{"key":"2026012202151213000_110.2.219.10","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/S0161-6420(01)00817-X","article-title":"Ocular manifestations of leukemia: leukemic infiltration versus infectious process","volume":"108","author":"Gordon","year":"2001","journal-title":"Ophthalmology"},{"key":"2026012202151213000_110.2.219.11","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.survophthal.2020.05.001","article-title":"Ophthalmic involvement of chronic lymphocytic leukemia: A systematic review of 123 cases","volume":"66","author":"Delestre","year":"2021","journal-title":"Surv Ophthalmol"},{"key":"2026012202151213000_110.2.219.12","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/ICU.0000000000000309","article-title":"Ophthalmic manifestations of leukemia","volume":"27","author":"Talcott","year":"2016","journal-title":"Curr Opin Ophthalmol"},{"key":"2026012202151213000_110.2.219.13","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.survophthal.2021.07.001","article-title":"Ophthalmologic manifestations as the initial presentation of chronic myeloid leukemia: A review","volume":"67","author":"Yassin","year":"2022","journal-title":"Surv Ophthalmol"},{"key":"2026012202151213000_110.2.219.14","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1989.01070010715033"},{"key":"2026012202151213000_110.2.219.15","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2021-243689","article-title":"Isolated optic nerve involvement in acute lymphoblastic leukaemia: a red flag for early relapse","volume":"14","author":"Azad","year":"2021","journal-title":"BMJ Case Rep"},{"key":"2026012202151213000_110.2.219.16","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1007\/s00277-024-05861-2","article-title":"Highlights of ophthalmological manifestations in newly diagnosed acute leukemia: a correlation with hematological parameters","volume":"103","author":"Laimon","year":"2024","journal-title":"Ann Hematol"},{"key":"2026012202151213000_110.2.219.17","article-title":"Leukemic Retinopathy: A Diagnostic Clue for Initial Detection and Prognosis of Leukemia","volume":"15","author":"Beketova","year":"2023","journal-title":"Cureus"},{"key":"2026012202151213000_110.2.219.18","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.1833000.x"},{"key":"2026012202151213000_110.2.219.19","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.3390\/cancers13092256","article-title":"Etiology of Acute Leukemia: A Review","volume":"13","author":"Tebbi","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2026012202151213000_110.2.219.20","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197610)38:4<1744::AID-CNCR2820380449>3.0.CO;2-3"},{"key":"2026012202151213000_110.2.219.21","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2024-205585","article-title":"Serious Bleeding Manifestations in Patients with Newly Diagnosed Acute Myeloid Leukemia: A Single Center Experience","volume":"144","author":"Abdulgayoom","year":"2024","journal-title":"Blood"},{"key":"2026012202151213000_110.2.219.22","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.2147\/OPTH.S342720","article-title":"Early Ophthalmological Manifestations of Acute Myeloid Leukemia: Current Perspectives","volume":"16","author":"El Salloukh","year":"2022","journal-title":"Clin Ophthalmol"},{"key":"2026012202151213000_110.2.219.23","first-page":"ND04","article-title":"Chronic Myeloid Leukaemia Presenting as Bilateral Retinal Haemorrhages with Multiple Retinal Infiltrates","volume":"10","author":"Rane","year":"2016","journal-title":"J Clin Diagn Res"},{"key":"2026012202151213000_110.2.219.24","doi-asserted-by":"crossref","DOI":"10.1186\/s13256-022-03700-4","article-title":"Leukemic retinopathy presenting as concurrent bilateral subhyaloid hemorrhage and subarachnoid hemorrhage in a patient with acute monocytic leukemia: a case report","volume":"16","author":"Ghanbarnia","year":"2022","journal-title":"J Med Case Rep"},{"key":"2026012202151213000_110.2.219.25","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.76.11.651"},{"key":"2026012202151213000_110.2.219.26","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1007\/s00417-007-0600-y","article-title":"Bilateral cystoid macular edema in a patient with chronic myeloid leukaemia under treatment with imanitib mesylate: report of an unusual side effect","volume":"245","author":"Georgalas","year":"2007","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2026012202151213000_110.2.219.27","doi-asserted-by":"crossref","unstructured":"Brown FE , Al-Janabi A , Gallagher K . Bilateral cystoid macular edema as the presenting feature of chronic myeloid leukemia. Retin Cases Brief Rep 2024. doi:10.1097\/ICB.0000000000001640","DOI":"10.1097\/ICB.0000000000001640"},{"key":"2026012202151213000_110.2.219.28","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.2147\/OPTH.S365648","article-title":"Ophthalmic Manifestations of Newly Diagnosed Acute Leukemia Patients in a Tunisian Cohort","volume":"16","author":"Sayadi","year":"2022","journal-title":"Clin Ophthalmol"},{"key":"2026012202151213000_110.2.219.29","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1200\/JCO.1989.7.10.1528","article-title":"A prospective ophthalmic evaluation of patients with acute myeloid leukemia: correlation of ocular and hematologic findings","volume":"7","author":"Karesh","year":"1989","journal-title":"J Clin Oncol"},{"key":"2026012202151213000_110.2.219.30","doi-asserted-by":"crossref","DOI":"10.1007\/s10792-024-03199-2","article-title":"Epiretinal membranes in patients with uveitis: an update on the current state of management","volume":"44","author":"Kalogeropoulos","year":"2024","journal-title":"Int Ophthalmol"},{"key":"2026012202151213000_110.2.219.31","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13020367","article-title":"Outcomes in the Treatment of Subretinal Macular Hemorrhage Secondary to Age-Related Macular Degeneration: A Systematic Review","volume":"13","author":"Confalonieri","year":"2024","journal-title":"J Clin Med"},{"key":"2026012202151213000_110.2.219.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2009.07.001"},{"key":"2026012202151213000_110.2.219.33","doi-asserted-by":"crossref","first-page":"148","DOI":"10.4103\/ijo.IJO_608_17","article-title":"Bilateral proliferative retinopathy in B-cell acute lymphoblastic leukemia","volume":"66","author":"Kumawat","year":"2018","journal-title":"Indian J Ophthalmol"},{"key":"2026012202151213000_110.2.219.34","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8635(18)30318-8"},{"key":"2026012202151213000_110.2.219.35","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2147\/BTT.S5775","article-title":"Principal long-term adverse effects of imatinib in patients with chronic myeloid leukemia in chronic phase","volume":"4","author":"Mughal","year":"2010","journal-title":"BTT"},{"key":"2026012202151213000_110.2.219.36","doi-asserted-by":"publisher","DOI":"10.1086\/648120"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjo-2025-327835","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T10:15:28Z","timestamp":1769076928000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjo-2025-327835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,28]]},"references-count":36,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,1,22]]},"published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10.1136\/bjo-2025-327835"],"URL":"https:\/\/doi.org\/10.1136\/bjo-2025-327835","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,28]]}}}